| Primary |
| Product Used For Unknown Indication |
43.2% |
| Drug Use For Unknown Indication |
16.5% |
| Hypertonic Bladder |
6.0% |
| Urinary Incontinence |
4.5% |
| Incontinence |
3.8% |
| Enuresis |
3.4% |
| Pollakiuria |
3.0% |
| Spinal Anaesthesia |
2.6% |
| Bladder Disorder |
2.3% |
| Cystitis Interstitial |
2.3% |
| Accidental Exposure |
1.5% |
| Hypertension |
1.5% |
| Neurogenic Bladder |
1.5% |
| Anxiety |
1.1% |
| Bladder Spasm |
1.1% |
| Glaucoma |
1.1% |
| Pain |
1.1% |
| Sedation |
1.1% |
| Stress Urinary Incontinence |
1.1% |
| Vulvovaginal Dryness |
1.1% |
|
| Muscle Spasms |
9.8% |
| Urinary Retention |
9.8% |
| Hyperthermia |
6.6% |
| Psychotic Disorder |
6.6% |
| Back Pain |
4.9% |
| Dry Mouth |
4.9% |
| Malaise |
4.9% |
| Medication Residue |
4.9% |
| Overdose |
4.9% |
| Product Substitution Issue |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Urticaria |
4.9% |
| Vision Blurred |
4.9% |
| Completed Suicide |
3.3% |
| Drug Ineffective |
3.3% |
| Incorrect Dose Administered |
3.3% |
| Infection |
3.3% |
| Mental Status Changes |
3.3% |
| Osteoarthritis |
3.3% |
| Paraesthesia |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
34.7% |
| Drug Use For Unknown Indication |
17.2% |
| Hypertonic Bladder |
10.6% |
| Urinary Incontinence |
4.7% |
| Depression |
3.8% |
| Hypertension |
3.3% |
| Pain |
3.3% |
| Neuropathy Peripheral |
3.0% |
| Pollakiuria |
2.6% |
| Diabetes Mellitus |
2.3% |
| Sleep Disorder |
2.3% |
| Bladder Disorder |
1.8% |
| Foetal Exposure During Pregnancy |
1.7% |
| Blood Pressure Increased |
1.5% |
| Cystitis Interstitial |
1.5% |
| Blood Cholesterol Increased |
1.2% |
| Breakthrough Pain |
1.2% |
| Incontinence |
1.2% |
| Thyroid Disorder |
1.2% |
| Cardiovascular Disorder |
1.1% |
|
| Drug Ineffective |
12.6% |
| Completed Suicide |
9.7% |
| Respiratory Arrest |
8.7% |
| Toxicity To Various Agents |
6.8% |
| Death |
5.8% |
| Adverse Drug Reaction |
4.9% |
| Constipation |
4.9% |
| Dry Mouth |
4.9% |
| Intentional Drug Misuse |
4.9% |
| Nausea |
4.9% |
| Cystitis |
3.9% |
| Drug Hypersensitivity |
3.9% |
| Urinary Incontinence |
3.9% |
| Abdominal Pain Upper |
2.9% |
| Dizziness |
2.9% |
| Dyspepsia |
2.9% |
| Dysuria |
2.9% |
| Familial Hypocalciuric Hypercalcaemia |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Localised Oedema |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.1% |
| Multiple Sclerosis |
8.2% |
| Drug Use For Unknown Indication |
8.1% |
| Hypertension |
5.5% |
| Pain |
4.8% |
| Depression |
3.8% |
| Rheumatoid Arthritis |
3.3% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Bladder Disorder |
2.7% |
| Diabetes Mellitus |
2.3% |
| Urinary Incontinence |
2.1% |
| Blood Cholesterol Increased |
1.9% |
| Osteoporosis |
1.8% |
| Anxiety |
1.7% |
| Asthma |
1.6% |
| Atrial Fibrillation |
1.6% |
| Multiple Myeloma |
1.5% |
| Hypertonic Bladder |
1.4% |
| Prophylaxis |
1.3% |
| Insomnia |
1.3% |
|
| Vomiting |
10.4% |
| Weight Decreased |
9.9% |
| Urinary Tract Infection |
9.2% |
| Death |
7.1% |
| Pain |
5.9% |
| Weight Increased |
5.5% |
| Drug Ineffective |
5.2% |
| Nausea |
4.7% |
| Fall |
4.1% |
| Multiple Sclerosis Relapse |
4.1% |
| Pain In Extremity |
4.0% |
| Dizziness |
3.6% |
| Dyspnoea |
3.6% |
| Fatigue |
3.6% |
| Vision Blurred |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Pneumonia |
3.3% |
| Pyrexia |
3.1% |
| Somnolence |
3.0% |
| Wrong Technique In Drug Usage Process |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Anxiety |
25.0% |
| Blood Cholesterol Increased |
12.5% |
| Hypothyroidism |
12.5% |
|
|
